117 related articles for article (PubMed ID: 38659261)
1. Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells.
Liao KS; Lee YR; Chao WY; Huang YJ; Chung HC; Chen SH; Li YZ; Zhao PW; Chang HY
Endocr Metab Immune Disord Drug Targets; 2024 Apr; ():. PubMed ID: 38659261
[TBL] [Abstract][Full Text] [Related]
2. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
Hu Y; Wen Q; Cai Y; Liu Y; Ma W; Li Q; Song F; Guo Y; Zhu L; Ge J; Zeng Q; Wang J; Yin C; Zheng G; Ge M
Phytomedicine; 2023 Jan; 108():154528. PubMed ID: 36343549
[TBL] [Abstract][Full Text] [Related]
3. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
4. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
[TBL] [Abstract][Full Text] [Related]
5. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Hahm ER; Singh SV
Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
[TBL] [Abstract][Full Text] [Related]
6. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in CAL-62 and BHT-101 Anaplastic Thyroid Carcinoma Cell Lines.
Shi XZ; Zhao S; Wang Y; Wang MY; Su SW; Wu YZ; Xiong C
Drug Des Devel Ther; 2023; 17():1889-1906. PubMed ID: 37397788
[TBL] [Abstract][Full Text] [Related]
8. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.
Prasad R; Kappes JC; Katiyar SK
Oncotarget; 2016 Feb; 7(7):7899-912. PubMed ID: 26760964
[TBL] [Abstract][Full Text] [Related]
10. Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells Via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor.
Fan Y; Xue W; Schachner M; Zhao W
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30587839
[TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level.
Wang MH; Ye Y; Zhang M; Zhou BR; Wang JN; Song YN; Xia W
Clin Transl Oncol; 2022 Feb; 24(2):288-296. PubMed ID: 34287816
[TBL] [Abstract][Full Text] [Related]
12. Honokiol inhibits migration of renal cell carcinoma through activation of RhoA/ROCK/MLC signaling pathway.
Cheng S; Castillo V; Welty M; Eliaz I; Sliva D
Int J Oncol; 2016 Oct; 49(4):1525-1530. PubMed ID: 27633759
[TBL] [Abstract][Full Text] [Related]
13. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Singh T; Katiyar SK
Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells.
Chou HC; Lu CH; Su YC; Lin LH; Yu HI; Chuang HH; Tsai YT; Liao EC; Wei YS; Yang YT; Chien YA; Yu XR; Lee YR; Chan HL
Life Sci; 2018 Aug; 207():184-204. PubMed ID: 29883720
[TBL] [Abstract][Full Text] [Related]
15. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.
Wu SM; Jan YJ; Tsai SC; Pan HC; Shen CC; Yang CN; Lee SH; Liu SH; Shen LW; Chiu CS; Arbiser JL; Meng M; Sheu ML
Cell Biol Toxicol; 2023 Oct; 39(5):1873-1896. PubMed ID: 34973135
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
[TBL] [Abstract][Full Text] [Related]
17. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits epithelial-mesenchymal transition and hepatic fibrosis via activation of Ecadherin/GSK3β/JNK and inhibition of AKT/ERK/p38/β-catenin/TMPRSS4 signaling axis.
Seo JH; Lee HJ; Sim DY; Park JE; Ahn CH; Park SY; Cho AR; Koo J; Shim BS; Kim B; Kim SH
Phytother Res; 2023 Sep; 37(9):4092-4101. PubMed ID: 37253375
[TBL] [Abstract][Full Text] [Related]
19. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
[TBL] [Abstract][Full Text] [Related]
20. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
Gao H; Wang W; Li Q
Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
